In-silico Investigation of Ginseng Phytoconstituents as Novel Therapeutics Against MAO-A


Citar

Texto integral

Resumo

Background:Ginseng (Panax ginseng) is a herb of medicinal and nutritional importance. Ginseng has been used since ancient times for the treatment of numerous ailments as it has many therapeutic properties. Several phytoconstituents are present in Panax ginseng that possess a variety of beneficial pharmacological properties.

Objective:To explore the potential of phytoconstituents of Panax ginseng in the treatment of depression, a molecular modeling technique was utilized targeting monoamine oxidase-A (MAO-A).

Methods:A total of sixty-one phytoconstituents of ginseng were drawn with the help of ChemBioDraw Ultra 12.0 software and PDBs for MAO-A enzyme were retrieved from the RCSB PDB database. The prepared ligands were screened for MAO-A properties using the software Molegro Virtual Docker (MVD 2010.4.1.0). All the prepared ligands were evaluated for drug-likeliness properties using Swiss ADME.

Result:Among the docking studies of 60 Ginseng phytochemicals including one standard, 15 phytoconstituents with the highest dock score and better binding interactions were selected further for absorption, distribution, metabolism and excretion (ADME) studies. Stachyose (-227.287, 17 interactions), Raffinose (-222.157, 14 interactions), and Ginsenoside Rg1 (-216.593, 10 interactions) were found to possess better interactions as compared to Clorgyline taken as a standard drug.

Conclusion:Stachyose was found to be the most potent inhibitor of MAO-A enzyme under investigation and can be a potential lead molecule for the development of newer phytochemical-based treatment of depression.

Sobre autores

Diksha Choudhary

Chitkara College of Pharmacy, Chitkara University

Email: info@benthamscience.net

Rajwinder Kaur

Chitkara College of Pharmacy, Chitkara University

Autor responsável pela correspondência
Email: info@benthamscience.net

Nidhi Rani

Chitkara College of Pharmacy, Chitkara University

Autor responsável pela correspondência
Email: info@benthamscience.net

Thakur Singh

Chitkara College of Pharmacy, Chitkara University

Email: info@benthamscience.net

Bhupinder Kumar

Department of Pharmaceutical Sciences, HNB Garhwal University

Email: info@benthamscience.net

Bibliografia

  1. Attele, A.S.; Wu, J.A.; Yuan, C.S. Ginseng pharmacology. Biochem. Pharmacol., 1999, 58(11), 1685-1693. doi: 10.1016/S0006-2952(99)00212-9 PMID: 10571242
  2. Coon, J.T.; Ernst, E. Panax ginseng. Drug Saf., 2002, 25(5), 323-344. doi: 10.2165/00002018-200225050-00003 PMID: 12020172
  3. Kiefer, D.; Pantuso, T. Panax ginseng. Am. Fam. Physician, 2003, 68(8), 1539-1542. PMID: 14596440
  4. Ru, W.; Wang, D.; Xu, Y.; He, X.; Sun, Y.E.; Qian, L.; Zhou, X.; Qin, Y. Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.). Drug Discov. Ther., 2015, 9(1), 23-32. doi: 10.5582/ddt.2015.01004 PMID: 25788049
  5. Liu, H.; Lu, X.; Hu, Y.; Fan, X. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. Pharmacol. Res., 2020, 161, 105263. doi: 10.1016/j.phrs.2020.105263 PMID: 33127555
  6. Lee, S.Y.; Kim, Y.K.; Park, N.I.; Kim, C.S.; Lee, C.Y.; Park, S.U. Chemical constituents and biological activities of the berry of Panax ginseng. J. Med. Plants Res., 2010, 4(5), 349-353.
  7. In, G.; Ahn, N.G.; Bae, B.S.; Lee, M.W.; Park, H.W.; Jang, K.H.; Cho, B.G.; Han, C.K.; Park, C.K.; Kwak, Y.S. In situ analysis of chemical components induced by steaming between fresh ginseng, steamed ginseng, and red ginseng. J. Ginseng Res., 2017, 41(3), 361-369. doi: 10.1016/j.jgr.2016.07.004 PMID: 28701878
  8. Qi, L.W.; Wang, C.Z.; Yuan, C.S. Isolation and analysis of ginseng: Advances and challenges. Nat. Prod. Rep., 2011, 28(3), 467-495. doi: 10.1039/c0np00057d PMID: 21258738
  9. Hou, J.P. The chemical constituents of ginseng plants. Comp. Med. East West, 1977, 5(2), 123-145. PMID: 608333
  10. Yun, T.K.; Lee, Y.S.; Lee, Y.H.; Kim, S.I.; Yun, H.Y. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci., 2001, 16(Suppl.), S6-S18. doi: 10.3346/jkms.2001.16.S.S6 PMID: 11748383
  11. Sun, Y.; Yang, Y.; Liu, S.; Yang, S.; Chen, C.; Lin, M.; Zeng, Q.; Long, J.; Yao, J.; Yi, F.; Meng, L.; Ai, Q.; Chen, N. New therapeutic approaches to and mechanisms of ginsenoside rg1 against neurological diseases. Cells, 2022, 11(16), 2529. doi: 10.3390/cells11162529 PMID: 36010610
  12. Kim, D.H. Chemical diversity of panax ginseng, panax quinquifolium, and panax notoginseng. J. Ginseng Res., 2012, 36(1), 1-15. doi: 10.5142/jgr.2012.36.1.1 PMID: 23717099
  13. Mehta, SD; Rathore, P; Rai, G Ginseng: Pharmacological action and phytochemistry prospective. In: Ginseng in Medicine; Intech, 2021. doi: 10.5772/intechopen.99646
  14. Hou, J.H.; Shin, H.; Shin, H.; Kil, Y.; Yang, D.H.; Park, M.K.; Lee, W.; Seong, J.Y.; Lee, S.H.; Cho, H.S.; Yuk, S.H.; Lee, K.Y. Influence of Panax ginseng formulation on skin microbiota: A randomized, split face comparative clinical study. J. Ginseng Res., 2022, 46(2), 296-303. doi: 10.1016/j.jgr.2021.12.002 PMID: 35509819
  15. Checkoway, H.; Lundin, J.I.; Kelada, S.N. Neurodegenerative diseases. IARC Sci. Publ., 2011, (163), 407-419. PMID: 22997874
  16. Finberg, J.; Youdim, M.B. Selective mao a and b inhibitors: Their mechanism of action and pharmacology. Neuropharmacology, 1983, 22(3), 441-446. doi: 10.1016/0028-3908(83)90194-6 PMID: 6304562
  17. Wadood, A.; Ahmed, N.; Shah, L.; Ahmad, A.; Hassan, H.; Shams, S. In-silico drug design: An approach which revolutionarised the drug discovery process. OA Drug Des Deliv, 2013, 1(1), 3.
  18. Karmazyn, M.; Gan, X.T. Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension. Mol. Cell. Biochem., 2021, 476(1), 333-347. doi: 10.1007/s11010-020-03910-8 PMID: 32940821
  19. Lee, S.M.; Bae, B.S.; Park, H.W.; Ahn, N.G.; Cho, B.G.; Cho, Y.L.; Kwak, Y.S. Characterization of korean red ginseng (Panax ginseng Meyer): History, preparation method, and chemical composition. J. Ginseng Res., 2015, 39(4), 384-391. doi: 10.1016/j.jgr.2015.04.009 PMID: 26869832
  20. Rani, N.; Singh, R.; Kumar, P. Molecular modeling study for the evaluation of natural compounds as potential lanosterol 14α-demethylase inhibitors. Lett. Drug Des. Discov., 2022, 19(5), 459-471. doi: 10.2174/1570180818666211027114007
  21. Rani, N; Kumar, P; Singh, R. Molecular modeling studies of halogenated imidazoles against 14α-demethylase from candida albicans for treating fungal infections. Infect. Disord. Drug Targets, 2020, 21(1), 90-117.
  22. Rani, N.; Dahiya, R.S.; Kumar, P. In silico studies of plant-derived bioactive compounds of wedelia species. Antiinfect. Agents, 2022, 20(5), e170522204885. doi: 10.2174/2211352520666220517094604

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bentham Science Publishers, 2024